SciELO - Scientific Electronic Library Online

 
vol.27 número6Evaluation of the treatment of valvular and non-valvular atrial fibrillation and its relationship with adverse events in patients admitted to the Emergency Department of a third level hospitalNatriuretic peptides in the detection of left ventricular dysfunction in a high risk population. A meta-analysis of diagnostic tests índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista Colombiana de Cardiología

versão impressa ISSN 0120-5633

Resumo

MENDOZA, Fernan et al. Financial burden of atrial defibrillation in Colombia. Rev. Colomb. Cardiol. [online]. 2020, vol.27, n.6, pp.541-547.  Epub 01-Ago-2021. ISSN 0120-5633.  https://doi.org/10.1016/j.rccar.2019.09.012.

Objective:

To determine the financial cost of atrial defibrillation in Colombia.

Materials and methods:

A retrospective study was carried out using health care data bases on patients with a diagnosis of atrial fibrillation. The patients were identified from the diagnoses recorded in ambulatory and hospital care registers, using the atrial fibrillation ICD-10 diagnostic (I48x). After the patients were identified, an algorithm was constructed by using the management guidelines for the disease and that simulated the natural history and care of the disease. A micro-costing technique was used in accordance with an official data base of a Colombian insurance Company, taking into account the natural history of the disease constructed.

Results:

The mean annual cost of a patient correctly diagnosed with atrial fibrillation is $6,218.179, that of the patient with an acute thrombo-embolic event or non-specific signs as a first manifestation of the disease is $23,665.300, and that of the patient with an infarction prior to the diagnosis of atrial fibrillation is $37,493.968.

Conclusions:

In terms of costs, the patient that is maintained under control, despite the technological costs of their control, is less costly than one that has acute episodes.

Palavras-chave : Atrial fibrillation; Cross-sectional studies; Economy; Healthcare costs.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )